ECG screening can assist in the detection of potentially life-threatening cardiac conditions, but legislation mandating preparticipation screening for young athletes may do more harm than good, ...

GE HealthCare has launched a new technology designed to help hospitals keep up with the maintenance and repair demands of a growing number of connected medical devices. The company has deployed the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

DiaCardia enables accurate prediabetes/diabetes screening using either 12-lead or single-lead electrocardiogram (ECG) data, demonstrating potential for scalable and accessible testing devices.

Please provide your email address to receive an email when new articles are posted on . Researchers trained a convolutional neural network with ECGs from patients with COPD and controls to detect COPD ...

DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either 12-lead or single-lead electrocardiogram (ECG) data, has been developed. This ...

A desktop application for visualizing multi-channel biological signals (ECG, EMG, EEG). Built with PyQt5, it supports reading from CSV/MAT files, real-time playback simulation, and interactive signal ...

More than $61 billion has flowed into the data center market so far this year. Hyperscalers are increasingly turning to outside capital in the form of debt to fund the energy-intensive infrastructure.

After receiving word late last month that the FDA would not be issuing a 510(k) clearance to its cable-free electrocardiogram, HeartBeam has successfully appealed the decision and now touts a green ...

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...

FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...